REGEN BIOPHARMA, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $20.50K.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $0.00.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $33.72K.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $13.04K.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2024 was $37.46K, a 87.51% decline from fiscal 2023.
- REGEN BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2023 was $300.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $20.50K 10-Q · filed 2026-05-14 | |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | |
| 2024-12-31 | $33.72K 10-Q · filed 2026-02-13 | |
| 2024-09-30 | $37.46K 10-K · filed 2025-12-30 | |
| 2024-06-30 | $13.04K 10-Q · filed 2025-08-11 | |
| 2023-09-30 | $300.00K 10-K · filed 2025-05-13 | |
| 2017-09-30 | $11.03K 10-K · filed 2018-12-27 | |
| 2017-03-31 | $13.40K 10-K · filed 2018-12-27 |